Institutional members access full text with Ovid®

Share this article on:

Extract of Clinopodium chinense Inhibits High Glucose–Induced Apoptosis in Human Umbilical Vein Endothelial Cells

Li, Juan MD*; Wu, Feihua PhD*; Chen, Kai MD; Liang, Jingyu MD; Ma, Shiping MD*

Journal of Cardiovascular Pharmacology: April 2013 - Volume 61 - Issue 4 - p 265–271
doi: 10.1097/FJC.0b013e31827d2a08
Original Article

Abstract: Endothelial dysfunction has been observed in diabetes mellitus, which is related to hyperglycemia. Previous studies have shown that incubation of human umbilical vein endothelial cells (HUVECs) in high glucose causes a significant increase in apoptosis, possibly related to an increase in oxidative stress. The present study aims at investigating the protective effects of Clinopodium chinense extract (CCE) on high glucose–induced apoptosis and the underlying mechanisms. We show that treatment of CCE significantly increased cell viability and the activity of superoxide dismutase, reduced oxidative stress, and protected HUVECs against apoptosis induced by high glucose. Furthermore, our results demonstrate that the antiapoptotic effect of CCE was associated with the reduction of Bax expression and caspase-3 activity and the elevation of Bcl-2 expression. The decrease in caspase-3 activity and caused by CCE were blocked by LY294002, a specific inhibitor of phosphatidylinositol 3-kinase, the upstream kinase of Akt. Moreover, treatment of CCE on HUVECs resulted in dose-dependenent phosphorylation of Akt and inhibited the activation of NF-κB. Taken together, our results indicate that CCE could play an important role in protecting endothelial cell by inhibiting oxidative stress and modulating cell apoptosis signaling via the pAkt/NF-κB/Bax/Bcl-2/caspase-3 pathway, suggesting that it might be useful for the treatment of endothelial dysfunction–associated diseases such as vascular complications of diabetes mellitus.

Departments of *Pharmacology for Chinese Materia Medica

Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing, Jiangsu, China.

Reprints: Feihua Wu, PhD, Department of Pharmacology for Chinese Materia Medica, China Pharmaceutical University, 639 Longmian Avenue, Jiangning District, Nanjing 211198, Jiangsu, China (e-mail:

Supported by National Natural Science Foundation of China (81102862), the Fundamental Research Founds for the Central Universities - China Pharmaceutical University (200908), and the Priority Academic Program Development of Jiangsu Higher Education Institutions.

The authors report no conflicts of interest.

Received June 16, 2012

Accepted November 07, 2012

© 2013 Lippincott Williams & Wilkins, Inc.